Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection

被引:7
作者
Chen, Shukkwan K. [1 ]
Hawley, Zachary C. E. [1 ]
Zavodszky, Maria I. [1 ]
Hana, Sam [1 ]
Ferretti, Daniel [1 ]
Grubor, Branka [1 ]
Hawes, Michael [2 ]
Xu, Shanqin [1 ]
Hamann, Stefan [1 ]
Marsh, Galina [1 ]
Cullen, Patrick [1 ]
Challa, Ravi [1 ]
Carlile, Thomas M. [1 ]
Zhang, Hang [1 ]
Lee, Wan-Hung [1 ]
Peralta, Andrea [1 ]
Clarner, Pete [1 ]
Wei, Cong [1 ]
Koszka, Kathryn [1 ]
Gao, Feng [1 ]
Lo, Shih-Ching [1 ]
机构
[1] Biogen, 225 Binney St, Cambridge, MA 02142 USA
[2] Charter Preclin Serv, Hudson, MA USA
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; ADENOASSOCIATED VIRUS; INTRATHECAL INJECTION; SPINAL-CORD; MUTANT SOD1; MICRORNA; SURVIVAL; NEURONS; DESIGN; GENE;
D O I
10.1016/j.omtn.2023.102057
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Toxic gain-of-function mutations in superoxide dismutase 1 (SOD1) contribute to approximately 2%-3% of all amyotrophic delivered by adeno-associated virus (AAV) have been proposed as a potential treatment option to silence SOD1 expression and mitigate disease progression. Primary microRNA (pri-miRNA) scaffolds are used in amiRs to shuttle a hairpin RNA into the endogenous miRNA pathway, but it is unclear whether different primary miRNA (pri-miRNA) scaffolds impact the potency and safety profile of the expressed amiR in vivo. In our process to develop an AAV amiR targeting SOD1, we performed a preclinical characterization of two pri-miRNA scaffolds, miR155 and miR30a, sharing the same guide strand sequence. We report that, while the miR155-based vector, compared with the miR30a-based vector, leads to a higher level of the amiR and more robust suppression of SOD1 in vitro and in vivo, it also presents significantly greater risks for CNSrelated toxicities in vivo. Despite miR30a-based vector showing relatively lower potency, it can significantly delay the development of ALS-like phenotypes in SOD1-G93A mice and increase survival in a dose-dependent manner. These data highlight the importance of scaffold selection in the pursuit of highly efficacious and safe amiRs for RNA interference gene therapy.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 56 条
[1]  
Al-Modawi R.N, 2021, Osteoarthr. Cartil. Open, V3
[2]   Structural Differences between Pri-miRNA Paralogs Promote Alternative Drosha Cleavage and Expand Target Repertoires [J].
Bofill-de Ros, Xavier ;
Kasprzak, Wojciech K. ;
Bhandari, Yuba ;
Fan, Lixin ;
Cavanaugh, Quinn ;
Jiang, Minjie ;
Dai, Lisheng ;
Yang, Acong ;
Shao, Tie-Juan ;
Shapiro, Bruce A. ;
Wang, Yun-Xing ;
Gu, Shuo .
CELL REPORTS, 2019, 26 (02) :447-+
[3]   Recombinant AAV as a Platform for Translating the Therapeutic Potential of RNA Interference [J].
Borel, Florie ;
Kay, Mark A. ;
Mueller, Christian .
MOLECULAR THERAPY, 2014, 22 (04) :692-701
[4]   Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo [J].
Boudreau, Ryan L. ;
Martins, Ines ;
Davidson, Beverly L. .
MOLECULAR THERAPY, 2009, 17 (01) :169-175
[5]   GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes [J].
Chan, Patricia P. ;
Lowe, Todd M. .
NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) :D184-D189
[6]   Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy [J].
Chandler, Randy J. ;
LaFave, Matthew C. ;
Varshney, Gaurav K. ;
Trivedi, Niraj S. ;
Carrillo-Carrasco, Nuria ;
Senac, Julien S. ;
Wu, Weiwei ;
Hoffmann, Victoria ;
Elkahloun, Abdel G. ;
Burgess, Shawn M. ;
Venditti, Charles P. .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (02) :870-880
[7]  
Dobin A, 2016, METHODS MOL BIOL, V1415, P245, DOI 10.1007/978-1-4939-3572-7_13
[8]   Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species [J].
Fader, Kelly A. ;
Pardo, Ingrid D. ;
Kovi, Ramesh C. ;
Somps, Christopher J. ;
Wang, Helen Hong ;
Vaidya, Vishal S. ;
Ramaiah, Shashi K. ;
Sirivelu, Madhu P. .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 25 :264-277
[9]   The Menu of Features that Define Primary MicroRNAs and Enable De Novo Design of MicroRNA Genes [J].
Fang, Wenwen ;
Bartel, David P. .
MOLECULAR CELL, 2015, 60 (01) :131-145
[10]   Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes [J].
Foust, Kevin D. ;
Nurre, Emily ;
Montgomery, Chrystal L. ;
Hernandez, Anna ;
Chan, Curtis M. ;
Kaspar, Brian K. .
NATURE BIOTECHNOLOGY, 2009, 27 (01) :59-65